GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹404 Cr | ₹875 Cr | ₹489 Cr | ₹222 Cr | ₹247 Cr |
What is the latest Short Term Loans and Advances ratio of GLAND PHARMA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹404 Cr |
| Mar2025 | ₹875 Cr |
| Mar2024 | ₹489 Cr |
| Mar2023 | ₹222 Cr |
| Mar2022 | ₹247 Cr |
How is Short Term Loans and Advances of GLAND PHARMA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹404 Cr | -53.84 | |
| Mar2025 | ₹875 Cr | 78.89 | |
| Mar2024 | ₹489 Cr | 119.92 | |
| Mar2023 | ₹222 Cr | -9.78 | |
| Mar2022 | ₹247 Cr | - | |
Compare Short Term Loans and Advances of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,653.4 Cr | 6.8% | 3.2% | 59.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 6.8% |
3.2% |
59.2% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses